A new approach to Medical Diagnosis – the SIFT-MS

A new approach to Medical Diagnosis – the SIFT-MS

Imagine breathing into a machine to diagnose a medical condition or disease. This could be the future of medicine according to Professor Richard Gearry.

The Bowel and Liver Trust is embarking on a new fundraising project to purchase a SIFT-MS machine. The project is a lofty goal as the machine plus research funding will mean we need to raise half a million dollars to ensure enough research can be done to make it worthwhile.

The SYFT-MS machine also known as the voice 250 can measure volatile organic compounds in breath or other gas samples.

Designed and Manufactured in Christchurch the primary use of this machine has been for detecting minute amounts of toxic gases in confined work spaces or other environments but medical researchers in Christchurch and elsewhere in the world have identified clinical uses for this technology.

A study titled - Breath Analysis Using SIFT-MS to Assess Metabolic Status in Patients After Gastro-oesophageal Cancer Surgery- a Pilot Study

Undertaken by Juzheng Huang# , Sacheen Kumar# , Piers R. Boshier, Stephanie Wakefield, Julia R. Cushnir and George B. Hanna*

Department of Surgery and Cancer, Imperial College London, 10th Floor QEQM Wing, St Mary’s Hospital, London, UK “demonstrates SIFT-MS to be a promising technique applicable in a clinical setting for the analysis of exhaled breath metabolites in patients with gastro-oesophageal cancer.”

Another study undertaken in Ohio titled - The Breathprints in Patients with Liver Disease Identify Novel Breath Biomarkers in Alcoholic Hepatitis and undertaken by Ibrahim A. Hanouneh, Nizar N. Zein, Frank Cikach, Luma Dababneh, David Grove, Naim Alkhouri, Rocio Lopez, Raed A. Dweik reached the following conclusion – “Based on levels of volatile compounds in breath samples, we can identify patients with AH vs patients with acute decompensation or individuals without liver disease. Levels of exhaled TMA moderately correlate with the severity of AH. These findings might be used in diagnosis of AH or in determining patient prognosis.”

Many of the Diagnostic tests for determining disease of the Gut are invasive and according to Professor Richard Geary Clinical Gastroenteroligist and Researcher simply breathing into a machine to diagnose a medical condition could be the way of the future.

Raising funds for such an important piece of research equipment that has the potential that SYFT-MS technology has is an exciting goal to be part of. Local Researchers plan to use the equipment to perform ground- breaking research in the following areas: Bowel Cancer, IBD (Crohn’s and ulcerative colitis), Irratable Bowel syndrom, Liver Disease,.

Contact us if you wish to find out more about this project and support this cause.